THERESA DYAR: Open Payments
NPI 1043404932 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 52 payments from 16 companies in 2025. Trend: 2023 $972 · 2024 $1,018 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $188 |
| PFIZER INC. | 12 | $166 |
| Novo Nordisk Inc | 6 | $104 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
Products named: QULIPTA, NURTEC ODT, VRAYLAR, Auvelity, EVENITY, Ozempic, ELIQUIS, Wegovy.
Industry payments across OH — which companies pay providers there.
